These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16515376)
1. Measuring value in the treatment of symptoms of allergic rhinitis with nasal steroids. Curtiss FR J Manag Care Pharm; 2006 Mar; 12(2):168-9, 171-2. PubMed ID: 16515376 [TBL] [Abstract][Full Text] [Related]
2. Willingness to pay for sensory attributes of intranasal corticosteroids among patients with allergic rhinitis. Mahadevia P; Shah S; Mannix S; Brewster-Jordan J; Kleinman L; Liebman C; O'Dowd L J Manag Care Pharm; 2006 Mar; 12(2):143-51. PubMed ID: 16515372 [TBL] [Abstract][Full Text] [Related]
3. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis. Reissman D; Price T; Leibman CW J Manag Care Pharm; 2004 Jan; 10(1 Suppl):S9-13. PubMed ID: 14720101 [TBL] [Abstract][Full Text] [Related]
4. Audit of nasal steroid use and effectiveness in a rhinitis clinic. Scadding G; Erkan AN; Chau H; Maskell S Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):87-90. PubMed ID: 20121566 [TBL] [Abstract][Full Text] [Related]
5. Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis. Wolthers OD Acta Paediatr; 2000 Oct; 89(10):1158-61. PubMed ID: 11083368 [TBL] [Abstract][Full Text] [Related]
6. Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis. Kennedy JL; Robinson D; Christophel J; Borish L; Payne S Am J Rhinol Allergy; 2014; 28(1):59-64. PubMed ID: 24717886 [TBL] [Abstract][Full Text] [Related]
8. Use of nasal steroids in managing allergic rhinitis. LaForce C J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 2):S388-94. PubMed ID: 10069899 [TBL] [Abstract][Full Text] [Related]
9. The cost of treating allergic rhinitis. Stempel DA; Woolf R Curr Allergy Asthma Rep; 2002 May; 2(3):223-30. PubMed ID: 11918864 [TBL] [Abstract][Full Text] [Related]
10. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829 [TBL] [Abstract][Full Text] [Related]
11. Nasal septal perforation in a patient with allergic bronchopulmonary aspergillosis and rhinitis on long term corticosteroids. Deepak D; Panjabi C; Gudwani S; Chaudhary N; Shah A Asian Pac J Allergy Immunol; 2001 Dec; 19(4):287-90. PubMed ID: 12009079 [TBL] [Abstract][Full Text] [Related]
12. Nasal budesonide efficacy for nasal nitric oxide and nasal obstruction in rhinitis. Ferrante G; Fasola S; Cilluffo G; Malizia V; Montalbano L; Landi M; Passalacqua G; La Grutta S Pediatr Allergy Immunol; 2017 Jun; 28(4):393-397. PubMed ID: 28218956 [No Abstract] [Full Text] [Related]
13. An overview of current pharmacotherapy in perennial rhinitis. Meltzer EO J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1097-110. PubMed ID: 7538519 [TBL] [Abstract][Full Text] [Related]
14. Recent progress in the treatment of nasal allergy, intranasal steroid treatment. Wihl JA Rhinology; 1984 Mar; 22(1):27-31. PubMed ID: 6729356 [No Abstract] [Full Text] [Related]
15. Lack of ocular side effects after 2 years of topical steroids for allergic rhinitis. Ozkaya E; Ozsutcu M; Mete F J Pediatr Ophthalmol Strabismus; 2011; 48(5):311-7. PubMed ID: 20964273 [TBL] [Abstract][Full Text] [Related]